Neuro-Oncology Reviews

Volume 24 Number 18
30 Settembre 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 18, 30 settembre

Aqel W, Salman A, Aldarawish A, Bakri I.
Medulloblastoma at the cerebello-pontine angle resembling vestibular schwannoma: A case report and review of the literature.
Int J Surg Case Rep. 2022 Sep 21;99:107695→. doi: 10.1016/j.ijscr.2022.107695→. PMID: 36162356→. Case report, Review. ˍ

El-Qutob D, Matheu V, Fernandez-Caldas E.
Allergen immunotherapy, cancer, and immune disorders.
Curr Opin Allergy Clin Immunol. 2022 Sep 21→. doi: 10.1097/ACI.0000000000000858→. PMID: 36165426→. Review˰ ˍ

Verdugo E, Puerto I, Medina MÁ.
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Cancer Commun (Lond). 2022 Sep 21→. doi: 10.1002/cac2.12361→. PMID: 36129048→. Review. ˍ

Li Y, Qin Q, Zhang Y, Cao Y.
Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis.
Curr Oncol. 2022 Sep 23;29(10):6893-6907→. doi: 10.3390/curroncol29100542→. PMID: 36290819→. Review. ˍ

Lim-Fat MJ, Macdonald M, Lapointe S, Climans SA, Cacciotti C, Chahal M, Perreault S, Tsang DS, Gao A, Yip S, Keith J, Bennett J, Ramaswamy V, Detsky J, Tabori U, Das S, Hawkins C.
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline.
Front Oncol. 2022 Sep 23;12:960509→. doi: 10.3389/fonc.2022.960509→. PMID: 36249063→. Guidelines. ˍ

Pinkiewicz M, Pinkiewicz M, Walecki J, Zawadzki M.
A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art.
Front Oncol. 2022 Sep 23;12:950167→. doi: 10.3389/fonc.2022.950167→. PMID: 36212394→. Review. ˍ

Voets NL, Bartsch AJ, Plaha P.
Functional MRI applications for intra-axial brain tumours: uses and nuances in surgical practise.
Br J Neurosurg. 2022 Sep 23:1-16→. doi: 10.1080/02688697.2022.2123893→. PMID: 36148501→. Review˰ ˍ

Sanati M, Binabaj MM, Ahmadi SS, Aminyavari S, Javid H, Mollazadeh H, Bibak B, Mohtashami E, Jamialahmadi T, Afshari AR, Sahebkar A.
Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation.
Biomed Pharmacother. 2022 Sep 24;155:113740→. doi: 10.1016/j.biopha.2022.113740→. PMID: 36166963→. Review. ˍ

Aiyappa-Maudsley R, Chalmers AJ, Parsons JL.
Factors affecting the radiation response in glioblastoma.
Neurooncol Adv. 2022 Sep 25;4(1):vdac156→. doi: 10.1093/noajnl/vdac156→. PMID: 36325371→. Review. ˍ

Bernstock JD, Hoffman SE, Kappel AD, Valdes PA, Essayed W, Klinger NV, Kang KD, Totsch SK, Olsen HE, Schlappi CW, Filipski K, Gessler FA, Baird L, Filbin MG, Hashizume R, Becher OJ, Friedman GK.
Immunotherapy approaches for the treatment of diffuse midline gliomas.
Oncoimmunology. 2022 Sep 26;11(1):2124058→. doi: 10.1080/2162402X.2022.2124058→. PMID: 36185807→. Review. ˍ

Rossi J, Cavallieri F, Biagini G, Rizzi R, Russo M, Cozzi S, Giaccherini L, Pisanello A, Valzania F.
Epileptogenesis and Tumorigenesis in Glioblastoma: Which Relationship?
Medicina (Kaunas). 2022 Sep 26;58(10):1349→. doi: 10.3390/medicina58101349→. PMID: 36295510→. Review. ˍ

Fougner V, Hasselbalch B, Lassen U, Weischenfeldt J, Poulsen HS, Urup T.
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.
Neurooncol Adv. 2022 Sep 28;4(1):vdac157→. doi: 10.1093/noajnl/vdac157→. PMID: 36325372→. Review. ˍ

Lopes J, Baudin C, Leuraud K, Klokov D, Bernier MO.
Ionizing radiation exposure during adulthood and risk of developing central nervous system tumors: systematic review and meta-analysis.
Sci Rep. 2022 Sep 28;12(1):16209→. doi: 10.1038/s41598-022-20462-7→. PMID: 36171442→. Review, Meta-analysis. ˍ

Soliman MA, Khan A, Azmy S, Gilbert O, Khan S, Goliber R, Szczecinski EJ, Durrani H, Burke S, Salem AA, Lubanska D, Ghannam MM, Hess RM, Lim J, Mullin JP, Davies JM, Pollina J, Snyder KV, Siddiqui AH, Levy EI, Plunkett RJ, Fenstermaker RA.
Meta-analysis of overall survival and postoperative neurologic deficits after resection or biopsy of butterfly glioblastoma.
Neurosurg Rev. 2022 Sep 29→. doi: 10.1007/s10143-022-01864-7→. PMID: 36173528→. Meta-analysis˰ ˍ

*

Song S, Wu H, Wang F, Jiao J, Xu L, Wang H, Tong X, Yan H.
Global research trends and hotspots on glioma stem cells.
Front Oncol. 2022 Sep 29;12:926025→. doi: 10.3389/fonc.2022.926025→. PMID: 36248966→. Bibliometric analysis. ˍ ˍ ˍ

Zhou Y, Fang C, Xu H, Yuan L, Liu Y, Wang X, Zhang A, Shao A, Zhou D.
Ferroptosis in glioma treatment: Current situation, prospects and drug applications.
Front Oncol. 2022 Sep 29;12:989896→. doi: 10.3389/fonc.2022.989896→. PMID: 36249003→. Review. ˍ

Park SH, Won JK, Kim CH, Phi JH, Kim SK, Choi SH, Chung CK.
Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience.
Neurospine. 2022 Sep 30;19(3):780-791→. doi: 10.14245/ns.2244196.098→. PMID: 36203303→. Review. ˍ

Sullivan JK, Fahey PP, Agho KE, Hurley SP, Feng Z, Day RO, Lim D.
Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis.
Neurooncol Pract. 2022 Sep 30, 2023;10(1):13-23→. doi: 10.1093/nop/npac078→. PMID: 36659976→. Review, Meta-analysis˰ ˍ